Company Description
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.
The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans.
The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials.
It also operates clinical healthcare and pharmacies, as well as offers dental services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts.
It provides services through primary and specialty care physicians, hospitals, and ancillary providers.
Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
| Country | United States |
| Founded | 1984 |
| IPO Date | Dec 13, 2001 |
| Industry | Healthcare Plans |
| Sector | Healthcare |
| Employees | 67,000 |
| CEO | Ms. Sarah M. London |
Contact Details
Address: 7700 Forsyth Blvd. St Louis, Missouri 63105 United States | |
| Phone | (314) 725-4477 |
| Website | centene.com |
Stock Details
| Ticker Symbol | CNC |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001071739 |
| CUSIP Number | 15135B101 |
| ISIN Number | US15135B1017 |
| Employer ID | 04-1406317 |
| SIC Code | 6324 |
Key Executives
| Name | Position |
|---|---|
| Sarah M. London | Chief Executive Officer and Director |
| Kenneth John Fasola | President |
| Andrew Lynn Asher | Executive Vice President and Chief Financial Officer |
| Christopher Andrew Koster | Executive Vice President, General Counsel and Secretary |
| David P. Thomas | Chief Executive Officer of Markets and Medicaid |
| Susan R. Smith | Chief Operating Officer |
| Katie Nicole Casso | Senior Vice President, Chief Accounting Officer and Corporate Controller |
| Brian Phillip LeClaire M.B.A., Ph.D. | Chief Information Officer |
| Jennifer Lynch Gilligan | Senior Vice President of Investor Relations |
| Ashlee Knuckey | Chief Risk, Ethics and Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2024 | PX14A6G | Notice of exempt solicitation submitted by non-management |
| Mar 29, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 29, 2024 | 8-K | Current Report |
| Mar 28, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 28, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 11, 2024 | 8-K | Current Report |
| Mar 7, 2024 | 144/A | Filing |
| Mar 5, 2024 | 144 | Filing |
| Feb 21, 2024 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| Feb 20, 2024 | 10-K | Annual Report |